This Nvidia Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
I'm LongbridgeAI, I can summarize articles.Top Wall Street analysts initiated coverage on several stocks this Friday. Baird rated Hubbell (HUBB) Outperform with a $550 target; BMO rated NVIDIA (NVDA) Outperform with a $340 target; Needham rated Faeth Therapeutics (FTH) Buy with a $56 target; Citizens rated Builders FirstSource (BLDR) Market Perform; and Cantor Fitzgerald rated Nuvation Bio (NUVB) Overweight.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Baird analyst Luke Junk initiated coverage on Hubbell Inc (NYSE:HUBB) with an Outperform rating and announced a price target of $550. Hubbell closed at $469.76 on Thursday. See how other analysts view this stock.
- BMO Capital analyst Harsh Kumar initiated coverage on NVIDIA Corp (NASDAQ:NVDA) with an Outperform rating and announced a price target of $340. Nvidia shares closed at $216.85 on Thursday. See how other analysts view this stock.
- Needham analyst Gil Blum initiated coverage on Faeth Therapeutics, Inc (NASDAQ:FTH) with a Buy rating and announced a price target of $56. Faeth Therapeutics closed at $32.10 on Thursday. See how other analysts view this stock.
- Citizens analyst James McCanless initiated coverage on Builders FirstSource, Inc. (NYSE:BLDR) with a Market Perform rating. Builders FirstSource shares closed at $70.32 on Thursday. See how other analysts view this stock.
- Cantor Fitzgerald analyst Li Watsek initiated coverage on Nuvation Bio Inc (NYSE:NUVB) with an Overweight rating. Nuvation Bio closed at $6.83 on Thursday. See how other analysts view this stock.
Considering buying AVGO stock? Here’s what analysts think:
Photo via Shutterstock